Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Clinical trial NCT00290433 · COMPLETED
Trial details
- NCT number
- NCT00290433
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2015-07-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.